This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...

FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.

The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus ...

A new technology has been developed that enables cuffless non-invasive blood pressure monitoring by using ultrasonic to track real-time changes in vascular diameter-without the need for a traditional ...

This all-purpose presence sensor is a master at monitoring indoor activity and linking it to smart home features you already use. For more than 10 years Tyler has used his experience in smart home ...

Aqara has announced the Spatial Multi-Sensor FP400, a new presence sensor that it says is precise enough to suss out whether you’re sitting, standing, or lying down. The FP400 builds on several past ...

Samsung is working on a new camera sensor, and once it finds its way into a next-gen Galaxy S-series device, it could help alleviate some of the brand’s problems with shutter speed. As reported by ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

I live in New Jersey, one of the states that mandates inspection for all vehicles newer than 1995. My daily driver, a Jeep Cherokee, happens to be a 1996 model year with an OBD-II sensor, meaning I ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven ...

Posts from this topic will be added to your daily email digest and your homepage feed. A single battery can power the MS605 mmWave radar presence sensor for up to three years. A single battery can ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...